TP53 and B-cell chronic lymphocytic leukemia: The CLL-international prognostic index (CLL-IPI) score is a prognostic score derived to identify high-risk disease by leveraging IGHV mutational status, age, stage, serum β2-microglobulin, and the presence of del(17p) and TP53 mutations.